RADHIKA RAO: Open Payments
NPI 1952485708 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,107 in 131 payments from 17 companies in 2025. Trend: 2023 $3,138 · 2024 $2,084 · 2025 $2,107
Food & beverage: $2,107
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 27 | $451 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $310 |
| ABBVIE INC. | 12 | $250 |
| E.R. Squibb & Sons, L.L.C. | 17 | $213 |
| Teva Pharmaceuticals USA, Inc. | 15 | $212 |
| Neurocrine BioSciences, Inc. | 11 | $176 |
| Axsome Therapeutics, Inc. | 9 | $144 |
| Tris Pharma Inc | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $52 |
Products named: REXULTI, CAPLYTA, VRAYLAR, COBENFY, INGREZZA, AUSTEDO XR, Auvelity, Dyanavel XR.
Industry payments across MO — which companies pay providers there.
